"This initial success with insurance coverage of ketamine is promising for the future of psychiatry because it sends a strong signal that payors are interested in more effective treatments for mental health conditions as supporting research emerges," said Dr. 1 While most insurance companies cover psychotherapy portions of this treatment, when used "off label" for psychiatric disorders, coverage for ketamine has typically been less common. Preliminary evidence suggests that when ketamine intervention is enhanced with therapeutic support, it may produce enduring benefits across a range of mental health disorders. Novamind administers ketamine in conjunction with psychotherapy, also known as ketamine-assisted psychotherapy. Ketamine has been safely used as an FDA approved anesthetic since 1970 and has found use in psychiatry to treat conditions including TRD.
(CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has obtained approval for direct billing of intravenous (IV) ketamine for treatment-resistant depression (TRD) from four major health insurance providers: Blue Cross Blue Shield, the University of Utah, PEHP Health & Benefits and MBA Benefit Administrators. TORONTO, ON / ACCESSWIRE / Novem/ Novamind Inc. Blue Cross added to list of insurance companies covering IV ketamine treatments at Novamind
0 kommentar(er)
